# Aurinia Pharmaceuticals Inc.: Form DEF 14A, filed May 3, 2024

- Company: [Aurinia Pharmaceuticals Inc.](/companies/auph.md) (CIK 1600620)
- Form: DEF 14A
- Filed: 2024-05-03
- Accepted by EDGAR: May 3, 2024, 16:08 ET
- Period: 2024-06-14
- Accession: 0001600620-24-000064
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1600620/000160062024000064/auph-20240502.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1600620/000160062024000064/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1600620/000160062024000064/auph-20240502.htm

Filed May 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001600620-24-000064. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.